Gilead will present real-world data on its efforts to advance WHO’s aim of eliminating viral hepatitis
News
Invizius’ ‘angry blood’ research recruits 300th patient
525-patient trial intends to assess ‘complement activation’ during HD in patients with end stage renal failure
Valneva reveals chikungunya vaccine data
VLA1553 had a high seroresponse rate among participants 28 days after receiving a single administration
Cardiff University begins study of schizophrenia therapy
The treatment candidate, known as MDI-26478, is a positive allosteric modulator of the AMPA receptor
Kite’s Yescarta and Tecartus therapies show promise
Objective response rate and complete response rates were encouraging for both treatments
Novartis reveals results from pivotal CML survey
International data questions the assumption that chronic myeloid leukaemia is now a ‘solved’ disease
Janssen reveals data from erdafitinib study
Erdafitinib boosted survival in patients with certain conditions including metastatic urothelial carcinoma
Linear Diagnostics develops 20-minute STI test
Emergence of quick test follows recent dramatic increase in sexually transmitted infections
Innovative CGT Catapult labs open doors
Laboratory space will accelerate the development of potentially life-saving cell therapies
Axol and StrataStem link up for Alzheimer’s disease trial
Companies will incorporate cells and technology to create a ‘clinical trial in a dish’
NICE nod for AstraZeneca’s Lynparza
Therapy treats patients with specific types of ovarian, fallopian tube or primary peritoneal cancer
New COVID-19 vaccine successfully tested
Rocketvax and Basel University therapy uses a modified coronavirus that activates an immune response
Biocomposites embraces NanoBone technology following acquisition of Artoss GmbH
The structure of NanoBone triggers bone-forming systems while also aiding rapid bone healing
AstraZeneca’s Tagrisso delivers positive results
Company’s phase 3 study showed treatment with Tagrisso reduced risk of death by over half
Element to increases lab equipment presence
New division aims to provide laboratories with the equipment and support to uphold analytical data
